Sugi Predict

Sugi Predict / Compounds / SCHEMBL10115468

SCHEMBL10115468

SCHEMBL10115468

Cc1c(NC(=O)CCCCNS(=O)(=O)C(C)C)ccc2ncsc12

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.40
▸ PKM P14618 1/20 0.40
▸ MAPK10 P53779 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ HDAC3 O15379 5/20 0.39
▸ HDAC1 Q13547 5/20 0.39
▸ HDAC6 Q9UBN7 5/20 0.37
▸ LMNA P02545 2/20 0.36
▸ NPY5R Q15761 2/20 0.36
▸ GRIA1 P42261 3/20 0.36
▸ HDAC4 P56524 1/20 0.35
▸ HDAC7 Q8WUI4 1/20 0.35
▸ HDAC2 Q92769 1/20 0.35
▸ HDAC10 Q969S8 1/20 0.35
▸ HDAC11 Q96DB2 1/20 0.35
▸ HDAC8 Q9BY41 1/20 0.35
▸ HDAC9 Q9UKV0 1/20 0.35
▸ HDAC5 Q9UQL6 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10115109 0.86 ALDH1A1 (0.40) ALDH1A1PKMMAPK10NPSR1HDAC3
SCHEMBL11935796 0.84 NPY5R (0.46) NPY5RGRIA1
SCHEMBL10115467 0.83 ALDH1A1 (0.37) ALDH1A1PKMMAPK10NPSR1HDAC3
SCHEMBL10115469 0.81 ALDH1A1 (0.41) ALDH1A1PKMMAPK10NPSR1HDAC3
SCHEMBL10113898 0.78 HDAC6 (0.47) ALDH1A1HDAC3HDAC1HDAC6LMNA
SCHEMBL10115353 0.77 KEAP1 (0.47) ALDH1A1NPSR1HDAC3HDAC1HDAC6
SCHEMBL10115470 0.74 ALDH1A1 (0.40) ALDH1A1HDAC3HDAC1HDAC6LMNA
SCHEMBL10115346 0.73 ALDH1A1 (0.41) ALDH1A1HDAC3HDAC1HDAC6LMNA
SCHEMBL10116586 0.73 NPC1 (0.40) ALDH1A1LMNA
SCHEMBL10115228 0.72 HDAC3 (0.47) ALDH1A1HDAC3HDAC1GRIA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8115027-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2012-02-14 — — US disclosed
US-8115027-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2012-02-14 — — US disclosed
US-20110039802-A1 NPY Y5 ANTAGONIST KAWANISHI YASUYUKI 2011-02-17 — — US disclosed
US-20100292500-A1 NPY Y5 ANTAGONIST KAWANISHI YASUYUKI 2010-11-18 — — US disclosed
US-20100292500-A1 NPY Y5 ANTAGONIST KAWANISHI YASUYUKI 2010-11-18 — — US disclosed
US-7781461-B2 NPY Y5 antagonist KAWANISHI YASUYUKI 2010-08-24 — — US disclosed
US-7781461-B2 NPY Y5 antagonist KAWANISHI YASUYUKI 2010-08-24 — — US disclosed
US-7265130-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2007-09-04 — — US disclosed
US-7265130-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2007-09-04 — — US disclosed
US-20070015762-A1 NPY Y5 antagonist KAWANISHI YASUYUKI 2007-01-18 — — US disclosed
US-20070015762-A1 NPY Y5 antagonist KAWANISHI YASUYUKI 2007-01-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070015762-A1 NPY Y5 antagonist NPY5R, NPY1R, NPY2R ALDH1A1 4558/4885PKM 4420/4885MAPK10 958/4885
US-20100292500-A1 NPY Y5 ANTAGONIST NPY5R, NPY1R, NPY2R ALDH1A1 4599/4885PKM 4271/4885MAPK10 919/4885
US-20110039802-A1 NPY Y5 ANTAGONIST NPY5R, NPY1R, NPY2R ALDH1A1 4517/4885PKM 4408/4885MAPK10 898/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.